Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Characterisation of human neuromuscular junctions in aging

EF 2017-18

Résumé
Characterisation of human neuromuscular junctions in aging: A progressive decrease in muscular function is one of the hallmarks of aging. It is caused by a loss of muscle mass named sarcopenia. It has a huge social and financial impact on society since the decrease in motility increases the risk of fall and hospitalisation, the development of several diseases and metabolic disorders and can lead to a premature death. The deterioration of the neuromuscular junction (NMJ), the only contact between the nervous system and the muscles, is thought to be a key factor in the development of sarcopenia. Even though its importance in the disorder has been recognized in several aging models, the human NMJ remains poorly characterized. Therefore, this project focuses on the characterisation of human NMJs and identification of neuromuscular biomarkers of aging. The project could result in a better understanding of the implication of the NMJ in sarcopenia and help identify novel therapeutic targets to develop better treatments in normal aging process but also in a pathological context such as in neurodegenerative disorders affecting the neuromuscular functions.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386354
Name
Marchand-Poirier Sandrine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterisation of human neuromuscular junctions in aging
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Human; Neuromuscular Junction; Neurosciences
Abstract
Characterisation of human neuromuscular junctions in aging: A progressive decrease in muscular function is one of the hallmarks of aging. It is caused by a loss of muscle mass named sarcopenia. It has a huge social and financial impact on society since the decrease in motility increases the risk of fall and hospitalisation, the development of several diseases and metabolic disorders and can lead to a premature death. The deterioration of the neuromuscular junction (NMJ), the only contact between the nervous system and the muscles, is thought to be a key factor in the development of sarcopenia. Even though its importance in the disorder has been recognized in several aging models, the human NMJ remains poorly characterized. Therefore, this project focuses on the characterisation of human NMJs and identification of neuromuscular biomarkers of aging. The project could result in a better understanding of the implication of the NMJ in sarcopenia and help identify novel therapeutic targets to develop better treatments in normal aging process but also in a pathological context such as in neurodegenerative disorders affecting the neuromuscular functions.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marchand-Poirier, Sandrine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~